8-K: Armata Pharmaceuticals Sets 2026 Annual Meeting Date
Annual Meeting Notice
Armata Pharmaceuticals has scheduled its 2026 annual meeting of stockholders for June 11, 2026.
Summary
- The 2026 annual meeting of stockholders is scheduled for June 11, 2026, at 8:30 a.m. PT.
- The meeting will take place at the company's headquarters in Los Angeles, California.
- Stockholders of record as of April 17, 2026, are eligible to vote.
- The deadline for submitting stockholder proposals and director nominations is April 12, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative update that carries no material impact on the company's financial or operational trajectory.
Positives
- Clear communication of corporate governance timelines.
- Established procedural transparency for stockholder participation.
Negatives
- Short window for stockholder proposals (deadline is April 12, 2026, only 10 days after the filing date).
Risks
- Potential for stockholder proposals to be excluded if they fail to meet the strict advance notice bylaw requirements by the April 12, 2026 deadline.
Future Outlook
The company is proceeding with standard annual corporate governance requirements to facilitate the 2026 annual meeting.
Industry Context
StockSavvy.ai notes that this is a routine administrative filing typical for publicly traded companies preparing for annual general meetings, ensuring compliance with NYSE American listing standards and internal bylaws.
Comparison to Industry Standards
- The timeline for the annual meeting and the advance notice period for proposals are consistent with standard corporate governance practices for small-cap biotechnology firms.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Meeting Scheduling | Formal scheduling of the 2026 Annual Meeting of Stockholders. | 2026-06-11 | Standard governance procedure; no material impact on operations. |
Stakeholder Impact
- Shareholders are provided with the necessary timeline to exercise their voting rights and submit proposals.
Next Steps
- Stockholders must submit proposals or nominations by April 12, 2026.
- Company to issue proxy statement for the Annual Meeting.
- Annual Meeting to be held on June 11, 2026.
Key Dates
| Date | Description |
|---|---|
| 2026-04-02 | Date of filing and announcement of meeting details. |
| 2026-04-12 | Deadline for receipt of stockholder proposals and director nominations. |
| 2026-04-17 | Record date for stockholders entitled to notice and to vote. |
| 2026-06-11 | Date of the 2026 annual meeting of stockholders. |
Keywords
Armata Pharmaceuticals, ARMP, Annual Meeting, Stockholder Proposals, Corporate Governance, Proxy Statement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.